Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: hameln pharmaceuticals ltd, Nexus, Gloucester Business Park, Gloucester, GL3 4AG, United Kingdom
Ephedrine Hydrochloride 30 mg/ml Solution for Injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. Clear, colourless and free of visible particles. |
Each 1 ml of solution for injection contains 30 mg ephedrine hydrochloride.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ephedrine |
Ephedrine is a sympathomimetic amine acting directly on the alpha and beta receptors and indirectly by increasing the release of noradrenaline by the sympathetic nerve endings. As with any sympathomimetic agent, ephedrine stimulates the central nervous system, the cardiovascular system, the respiratory system, and the sphincters of the digestive and urinary systems. |
| List of Excipients |
|---|
|
Water for injections |
1 ml colourless glass one-point-cut (OPC) ampoules, type I containing 1 ml solution for injection. Packed into cartons of 5 or 10 ampoules.
Not all pack sizes may be marketed.
hameln pharmaceuticals ltd, Nexus, Gloucester Business Park, Gloucester, GL3 4AG, United Kingdom
PL 01502/0103
08/06/2018
| Drug | Countries | |
|---|---|---|
| EPHEDRINE | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
